FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, potassium chloride, calcium chloride
LOE Approaching
B
Baxter
INJECTION · INJECTABLE
1985
NDA
30/100
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, and potassium chloride
LOE Approaching
OtsukaOtsuka
INJECTION · INJECTABLE
sodium chloride
1980
NDA
30/100
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
dextrose; potassium chloride; sodium chloride
LOE Approaching
ICU MedicalICU Medical
INJECTION · INJECTABLE
1986
NDA
30/100
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
potassium chloride, dextrose monohydrate and sodium chloride
LOE Approaching
B
Baxter
INJECTION · INJECTABLE
1979
NDA
30/100
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, and potassium chloride
LOE Approaching
OtsukaOtsuka
INJECTION · INJECTABLE
sodium chloride
1980
NDA
30/100
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, and potassium chloride
LOE Approaching
OtsukaOtsuka
INJECTION · INJECTABLE
sodium chloride
1988
NDA
30/100
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
potassium chloride, dextrose monohydrate and sodium chloride
LOE Approaching
B
Baxter
INJECTION · INJECTABLE
1985
NDA
30/100
POTASSIUM CITRATE
potassium citrate
LOE Approaching
ORAL · FOR SOLUTION
1988
NDA
30/100
POTASSIUM IODIDE
potassium iodide
LOE Approaching
ORAL · SOLUTION
1982
NDA
30/100
POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
potassium phosphates in sodium chloride
Growth
INTRAVENOUS · SOLUTION
2024
NDA
30/100
POTIGA
ezogabine
Peak
GSKGSK
ORAL · TABLET
2011
NDA
30/100
POVIDONE IODINE
povidone-iodine
LOE Approaching
BayerBayer
TOPICAL · SOLUTION
1989
NDA
30/100
PRALIDOXIME CHLORIDE
pralidoxime chloride
LOE Approaching
B
Baxter
INJECTION · INJECTABLE
1982
NDA
30/100
PRALIDOXIME CHLORIDE (AUTOINJECTOR)
pralidoxime chloride
LOE Approaching
CooperSurgicalCooperSurgical
INTRAMUSCULAR · SOLUTION
1983
NDA
30/100
PRANDIMET
metformin hydrochloride; repaglinide
LOE Approaching
Novo NordiskNovo Nordisk
ORAL · TABLET
2008
NDA
30/100
PRANDIN
repaglinide
LOE Approaching
ORAL · TABLET
1997
NDA
30/100
PRAVACHOL
pravastatin sodium
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · TABLET
1991
NDA
30/100
PRAVIGARD PAC (COPACKAGED)
aspirin; pravastatin sodium
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · TABLET
2003
NDA
30/100
PRE-OP
hexachlorophene
LOE Approaching
TOPICAL · SPONGE
1978
NDA
30/100
PRE-OP II
hexachlorophene
LOE Approaching
TOPICAL · SPONGE
1978
NDA
30/100
PRECEF
ceforanide
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
INJECTION · INJECTABLE
1984
NDA
30/100
PRECOSE
acarbose
LOE Approaching
BayerBayer
ORAL · TABLET
1995
NDA
30/100
PRED FORTE
prednisolone acetate
LOE Approaching
AbbVieAbbVie
OPHTHALMIC · SUSPENSION/DROPS
steroid-responsive inflammation of the palpebralbulbar conjunctiva+2
1973
NDA
30/100
PRED MILD
prednisolone acetate
LOE Approaching
AbbVieAbbVie
OPHTHALMIC · SUSPENSION/DROPS
mild to moderate noninfectious allergicinflammatory disorders of the lid+4
1972
NDA
30/100
← PreviousPage 143 of 277Next →